Key result
Major barriers to optimal hypertension control include patient-related factors like poor medication adherence and physician-related factors such as clinical inertia.
Highlights that medication adherence and clinical inertia are the most salient patient- and physician-related barriers to optimal hypertension control.
Unaddressed adherence barriers limit BP control translation; leaves open effective implementation strategies.
There is an obvious gap in the translation of clinical trial evidence into practice with regards to optimal hypertension control. The three major categories of barriers to BP control are patient-related, physician-related, and medical environment/health care system factors. Patient-related barriers include poor medication adherence, beliefs about hypertension and its treatment, depression, health literacy, comorbidity, and patient motivation. The most pertinent is medication adherence, given its centrality to the other factors. The most salient physician-related barrier is clinical inertia--defined, as the failure of health care providers to initiate or intensify drug therapy in a patient with uncontrolled BP. The major reasons for clinical inertia are: 1) overestimation of the amount of care that physicians provide; 2) lack of training on how to attain target BP levels; and 3) clinicians' use of soft reasons to avoid treatment intensification by adopting a "wait until next visit" approach in response to patients' excuses.
No takes yet. Share an insight, caveat, or question.
Gbenga Ogedegbe (2008) conducted a review in Hypertension. Major barriers to optimal hypertension control include patient-related factors like poor medication adherence and physician-related factors such as clinical inertia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: